A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review

Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the development of specific autoantibodies against factor VIII (FVIII). Immunotherapy is a recent therapeutic option that targets the patient’s self-tolerance against tumor cells. Because therapeutic effects of the immune checkpoint i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gidaro, Antonio, Palmieri, Giuseppe, Donadoni, Mattia, Mameli, Lucia A., La Cava, Leyla, Sanna, Giuseppe, Castro, Dante, Delitala, Alessandro P., Manetti, Roberto, Castelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600358/
https://www.ncbi.nlm.nih.gov/pubmed/36292248
http://dx.doi.org/10.3390/diagnostics12102559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600358/
https://www.ncbi.nlm.nih.gov/pubmed/36292248
http://dx.doi.org/10.3390/diagnostics12102559

Ejemplares similares